Skip to main content

Boneless chicken is first to go scarce as coronavirus hits U.S. meat supply

Goodbye, boneless chicken.

Food retailers across North America are swapping boneless chicken legs for less popular thighs and drumsticks as a wave of shutdowns at meatpacking plants has reduced supplies of sought-after cuts.

Covid-19 infections among workers at some of the largest meat processing plants in the U.S. and Canada have reduced slaughter capacity, and in some cases the types of cuts available. Outbreaks have shut down almost a third of U.S. pork capacity and the growing wave of disruptions has spurred plans by President Donald Trump to order meat-processing plants to remain open. In Canada, Cargill Inc. has idled its beef plant in High River, Alberta, which accounts for about 40% of Canada’s processing capacity while JBS SA’s beef plant in Brooks, Alberta, is running at about half capacity.

Quebec-based Goodfood Market Corp., which delivers meals on a subscription basis, said it will be substituting its regular boneless chicken for bone-in thighs, legs and drumsticks as the poultry industry shifts away from de-boning to ramp up production.

“Poultry suppliers are still facing labor shortages and many of them are operating with less than 50% of their regular workforce,” Goodfood Chief Executive Officer Jonathan Ferrari wrote in an email to customers. “To ensure the essential supply of chicken for Canadians across the country, the poultry industry as a whole is shifting away from de-boning chicken legs to increase their production capacity.”

Ferrari also wrote that the company is working to secure a frozen beef supply in case shutdowns at Alberta’s beef suppliers disrupt the supply chain.

New Meat Selection

Grocers generally are accepting cuts of meat that require more cutting by their in-house butchers to keep their meat counters as full as possible, said Michael Young, president of Canada Beef.

Meat such as sirloin and strip loins that would have typically been sent to restaurants before the pandemic shuttered businesses are now increasingly sold by retailers who are offering them in different sizes to get the price point down, he said. Companies are taking products that would have been used by the food service industry and redirecting it for retail sale. That means forgoing thin-cut meats that would require more time to process.

Grocers are also trying to find a way to sell so-called “end cuts” from the leg or trunk that consumers may be unfamiliar with. That includes promoting the idea of grilling marinated round steaks — from the leg of a cow — on the barbecue to make it more tender, Young said.

Larger Packages

Consumers in grocery stores around the world might notice larger packages of meat instead of individual steaks or smaller portions, said Brian Sikes, head of Cargill’s protein and salt businesses. While the company’s plants primarily produce the same products for retail and food-service, they might cut or package them slightly differently, he said.

“We know they’re buying cuts that they’ve never bought before,” Young said Wednesday by telephone.

Even in Europe, where supply disruptions have not been as severe, grocers are trying to get retail customers to eat cuts of meat that restaurants usually buy. In the U.K., there’s been an uptick in sales of steaks and other cuts of meat less popular with retail customers, according to Nick Allen, chief executive of the British Meat Processors’ Association. Big retailers have been putting these cuts on sale to encourage shoppers to buy, Allen said. A lot more ground meat is typically sold by comparison, which causes an imbalance.

“We’re just waiting to see if enough has changed to eat our way out of the problem,” Allen said.

More coronavirus coverage from Fortune:

—What the law says about forcing employees back to the office
Alphabet and Facebook earnings are expected to be bad. The question is how bad?
How the U.S. should invest in public health before reopening the economy
—Tech issues and backlogs hit the SBA’s second round of PPP loans
—There may be 22 hidden coronavirus hotspots in states poised to lift restrictions
—Coronavirus brought China’s travel industry to a standstill. Now it’s showing signs of life
—The coronavirus pandemic is impacting critical research into neuromuscular diseases
—PODCAST: How 2 CEOs outside of health care decided to pivot to fight COVID-19
—WATCH: Fortune’s top 10 heroes of the coronavirus pandemic

Subscribe to Outbreak, a daily newsletter roundup of stories on the coronavirus pandemic and its impact on global business. It’s free to get it in your inbox.



from Fortune https://ift.tt/2y9Kgp9

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be